Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history

Article Abstract:

It may be difficult to determine which groups of American women should be screened for mutations in the BRCA1 gene. These mutations have been linked to an increased risk of breast and ovarian cancer. Researchers tested two groups of women who might be considered at high risk of having a mutation: 193 women diagnosed with breast cancer before the age of 35 and 208 women diagnosed before the age of 45 who had a family history of breast cancer. Only 6% of the first group and 7% of the second group had a BRCA1 mutation. Women with more than one relative with breast cancer or relatives with ovarian cancer were more likely to have a mutation.

Author: Daling, Janet R., Ostrander, Elaine A., Malone, Kathleen E., Thompson, Jennifer D., O'Brien, Cecilia A., Francisco, Leigh V.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 1998
Testing, Gene mutations, Gene mutation, Genetic aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Trends in incidence rates of invasive lobular and ductal breast carcinoma

Article Abstract:

The increased risk of breast cancer caused by some types of hormone replacement therapy appears to be limited to invasive lobular breast cancer, according to researchers who analyzed data from nine cancer registries between 1987 and 1999. During that time, invasive lobular breast cancer increased from 9% of all breast cancer cases to 16% of all breast cancer cases. This type of cancer is not common, but is more difficult to detect on mammograms.

Author: Daling, Janet R., Moe, Roger E., Li, Christopher I., Anderson, Benjamin O.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2003
Labor Distribution by Employer, Statistics

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

Article Abstract:

Hormone replacement therapy consisting of estrogen and progestin may increase a woman's risk of breast cancer, according to a study of 975 women. They had a higher risk of developing invasive lobular breast cancer than non-users, especially if they used hormone replacement therapy for more than five years. This was true whether they took the progestin sequentially or continually.

Author: Weiss, Noel S., Daling, Janet R., Li, Christopher I., Malone, Kathleen E., Porter, Peggy L., Tang, Mei-Tzu, Cushing-Haugen, Kara L.
Publisher: American Medical Association
Publication Name: JAMA, The Journal of the American Medical Association
Subject: Health
ISSN: 0098-7484
Year: 2003

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Breast cancer, Complications and side effects, Risk factors, Hormone therapy, Hormone replacement therapy
Similar abstracts:
  • Abstracts: Differences in oxidative response of subpopulations of neutrophils from healthy subjects and patients with rheumatoid arthritis
  • Abstracts: Characteristics of oral cancer in a central European population: defining the dentist's role. Risk management considerations for oral cancer
  • Abstracts: Emergency care how A&E nurses are hitting the target: in the drive to ensure that all patients are in and out of A&E as fast as possible, nurses' roles are changing rapidly
  • Abstracts: Low-fat dietary pattern and risk of invasive breast cancer: The women's health initiative randomized dietary modification trial
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.